Relugolix, Estradiol, and Norethindrone Acetate.
出版信息
Am J Health Syst Pharm. 2021 Sep 22;78(19):1755-1760. doi: 10.1093/ajhp/zxab268.
PMID:34286333
Abstract
摘要
相似文献
1
Relugolix, Estradiol, and Norethindrone Acetate.
Am J Health Syst Pharm. 2021 Sep 22;78(19):1755-1760. doi: 10.1093/ajhp/zxab268.
2
Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain.
Drugs. 2024 Apr;84(4):449-457. doi: 10.1007/s40265-024-02018-3. Epub 2024 Apr 9.
3
An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Expert Opin Pharmacother. 2022 Mar;23(4):421-429. doi: 10.1080/14656566.2022.2030705. Epub 2022 Jan 24.
4
Myfembree for fibroid-associated heavy menstrual bleeding.
Med Lett Drugs Ther. 2021 Aug 9;63(1630):121-123.
5
A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women.
Clin Pharmacokinet. 2023 Aug;62(8):1169-1182. doi: 10.1007/s40262-023-01269-9. Epub 2023 Jun 26.
6
A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone.
Am J Obstet Gynecol. 2003 Feb;188(2):334-42. doi: 10.1067/mob.2003.91.
7
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group.
Obstet Gynecol. 1999 Oct;94(4):498-503. doi: 10.1016/s0029-7844(99)00359-2.
8
Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):7-12. doi: 10.1016/s0002-9378(00)70483-2.
9
Norethindrone acetate and estradiol-induced endometrial hyperplasia.
Obstet Gynecol. 2000 Sep;96(3):373-9. doi: 10.1016/s0029-7844(00)00944-3.
10
Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch.
Contact Dermatitis. 2001 Feb;44(2):112-3. doi: 10.1034/j.1600-0536.2001.44020914.x.
引用本文的文献
1
Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women.
Pharmacol Res Perspect. 2025 Feb;13(1):e70067. doi: 10.1002/prp2.70067.
2
An Efficient UPLC-MS/MS Method Established to Detect Relugolix Concentration in Rat Plasma.
Front Pharmacol. 2022 Jun 16;13:874973. doi: 10.3389/fphar.2022.874973. eCollection 2022.
3
An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Expert Opin Pharmacother. 2022 Mar;23(4):421-429. doi: 10.1080/14656566.2022.2030705. Epub 2022 Jan 24.
Zotero 插件